Sort
50,496 grants matching “lung cancer”
Analyses of the Molecular Functions for D-Cyclins
$417,290Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Mechanism of chemotherapy potentiation of muscle wasting in cancer cachexia
$417,286Yi-Ping Li · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · CA
Mechanism of chemotherapy potentiation of muscle wasting in cancer cachexia
$417,286Yi-Ping Li · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · CA
Phase III Trial of Exercise Training in Postsurgical Lung Cancer
$417,275Lee W Jones · Duke University · R01 · FY2010 · CA
Metabolic Adaptive Responses in Cancer
$417,215David R Plas · University Of Cincinnati · R01 · FY2015 · CA
Developmental Funds
$417,200Caryn Lerman · University Of Southern California · P30 · FY2025 · CA
Occupational and Environmental Determinants of Cancer among Women and Minorities
$417,200Laura Beane Freeman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
LACE-Bio-II: Identification, validation and implementation of prognostic and/or p
$417,115Lesley Katie Seymour · Queen'S University At Kingston · R01 · FY2013 · CA
Damage Sensing and Growth Control in the Drosophila Gut
$417,083Bruce A Edgar · University Of Utah · R01 · FY2017 · GM
Identifying Genes that Cause Lung Cancer to Progress
$417,058California Pacific Med Ctr Res Institute · R01 · FY2004 · CA
Novel Reagents and New Biomarkers for Lung Cancer
$417,050University Of Texas Sw Med Ctr/Dallas · U01 · FY2004 · CA
Advanced Imaging Core
$417,032David Entenberg · Albert Einstein College Of Medicine · P01 · FY2022 · CA
Crosstalk Between Metabolism and Inflammation in Pulmonary Hypertension
$417,007Kurt R Stenmark · University Of Colorado Denver · P01 · FY2016 · HL
Crosstalk Between Metabolism and Inflammation in Pulmonary Hypertension
$417,007Kurt R Stenmark · University Of Colorado Denver · P01 · FY2017 · HL
Autophagy Heterogeneity and Tumor Metastasis
$417,005Hong-Gang Wang · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2021 · CA
Project 1: Glutaminolytic GDH1 activation-dependent immunotherapy resistance in LKB1-mutant lung adenocarcinoma
$416,967Sumin Kang · Emory University · P01 · FY2023 · CA
Discovery and therapeutic targeting of biological determinants of lung cancer health disparities
$416,907Sharon R. Pine · Rbhs -Cancer Institute Of New Jersey · R01 · FY2020 · CA
Metabolic Adaptive Responses in Cancer
$416,900David R Plas · University Of Cincinnati · R01 · FY2016 · CA
Metabolic Adaptive Responses in Cancer
$416,900David R Plas · University Of Cincinnati · R01 · FY2017 · CA
Improving CAR-T cell therapy in metastatic breast cancers by reprogramming obesity-aggravated tumor microenvironment via physical activity
$416,818Dai Fukumura · Massachusetts General Hospital · R21 · FY2025 · CA
Effects of Complement on the Tumor Microenvironment in Lung Cancer
$416,813Raphael A. Nemenoff · University Of Colorado Denver · R01 · FY2019 · CA
Project 3 Immunotherapeutic Targeting of SLC45A2 for Treatment of Uveal Melanoma
$416,787Cassian Yee · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Project 3 Immunotherapeutic Targeting of SLC45A2 for Treatment of Uveal Melanoma
$416,783Cassian Yee · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
Role of Formylpeptide Receptors in Host Defense
$416,783Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
SOUTHWEST ONCOLOGY GROUP--SUMMARY
$416,726Loyola University Chicago · U10 · FY2002 · CA